High-grade serous ovarian cancer (HGSOC) presents challenges in prognostic prediction. This study aimed to develop a universal foundation model-driven multimodal model (FoMu model) to assess the ...

In their research, scientists have identified a change in gene expression in the placenta of pregnant women with cancer. The ...

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.

Q1 2025 Earnings Call Transcript May 2, 2025 Fulgent Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.37396 EPS, expectations were $-0.19. Melanie Solomon: Greetings and welcome to ...

Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Hello and welcome to the Summit ...

Most skin cancers are treatable, mainly if they're found early. Regular skin checks are an important part of your health ...

Read the full guideline update, “Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update” at ... immunotherapy, chemotherapy, pathology, and germline testing. Dr.

Ovarian cancer (OC) remains a formidable challenge due to limited ... with maytansinoids yielding the best overall therapeutic index across of broad spectrum of OC histologic subtypes. Conclusion: The ...

We have used mutation testing data from 4115 unrelated samples from affected non-Jewish individuals alongside tumour pathology to further refine the scoring system. Results Adding additional points ...

University of Chicago Pritzker School of Medicine, Chicago, IL.

Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, ...